PC-PLD Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of PC-PLD monoclonal antibodies for research focused on understanding phosphatidylcholine-specific phospholipase D (PC-PLD) in various biological processes. PC-PLD monoclonal antibodies are suitable for multiple applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PC-PLD is a critical enzyme involved in the hydrolysis of phosphatidylcholine, leading to the production of phosphatidic acid, which plays a significant role in cell signaling, membrane dynamics, and the regulation of various cellular processes. PC-PLD research has significant implications in cancer research, neurobiology, and inflammation studies, making it a key target for therapeutic interventions. Understanding PC-PLD function and regulation can provide insights into disease mechanisms and potential treatment strategies. Researchers can leverage PC-PLD monoclonal antibodies to explore cellular pathways and molecular mechanisms. Santa Cruz Biotechnology monoclonal antibodies enable scientists worldwide to advance their understanding of PC-PLD and its role in human health and disease.